§ 24:6I-19 — Standardized requirements, procedures for testing.

26. a. The commission shall establish, by regulation, standardized requirements and procedures for testing medical cannabis and medical cannabis products. b. Any test performed on medical cannabis or on a medical cannabis product shall include liquid chromatography analysis to determine chemical composition and potency, and, at a minimum, screening for each of the following: (1) microbial contamination; (2) foreign material; (3) residual pesticides; (4) other agricultural residue and residual solvents; and (5) heavy metals. c. Laboratories shall use the dosage equivalence guidelines developed by the commission pursuant to paragraph (2) of subsection c. of section 18 of P.L.2009, c.307 (C.24:6I-16) when testing and determining the potency of medical cannabis products. d. As a condition of licensure, each laboratory shall certify its intention to seek third party accreditation in accordance with ISO 17025 standards in order to ensure equipment is routinely inspected, calibrated, and maintained until such time as the commission issues its own standards or confirms the use of ISO 17025. e. Until such time as the commission establishes the standards required by this section, a licensed laboratory shall utilize the testing standards established by another state with a medical cannabis program, which state shall be designated by the commission. L.2019, c.153, s.26.